HCA reports higher second-quarter earnings but lowers 2026 guidance

HCA Healthcare reported second-quarter 2026 revenue of $20.230 billion, net income of $1.699 billion, and diluted EPS of $7.62 for the period ended June 30, up from the prior year, while operating cash flow fell to $2.335 billion from $4.210 billion. HCA lowered its 2026 guidance to revenue of $77.0 billion-$79.5 billion, net income of $6.3 billion-$6.7 billion, adjusted EBITDA of $15.4 billion-$16.1 billion, and diluted EPS of $28.70-$30.50, citing an estimated $400 million second-quarter pretax impact from a shift toward uninsured patients; the company also declared a $0.78 quarterly dividend payable September 30 to shareholders of record September 16.